Drugs / Levomethadone

Trials 2

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT05251376 Feb → Dec 2022 opiate dependence Lyndra Inc. Withdrawn No outcome recorded Stop: Business
Phase 41 trial
Phase 4 NCT04254731 May 2015 → Jun 2018 cardiac rhythm disease Oslo University Hospital Unknown No outcome recorded

Evidence & citations 13 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as levomethadone ClinicalTrials.gov intervention name — accepted as the source's own label NCT04254731 ↗
1

NCT05251376 ↗

Known as (6r)-methadone ChEMBL registry synonym — accepted as the source's own label CHEMBL159659 ↗
Known as D-(-)-methadone ChEMBL registry synonym — accepted as the source's own label CHEMBL159659 ↗
Known as L-methadone ChEMBL registry synonym — accepted as the source's own label CHEMBL159659 ↗
Known as L-polamivet ChEMBL registry synonym — accepted as the source's own label CHEMBL159659 ↗
Known as Levadone ChEMBL registry synonym — accepted as the source's own label CHEMBL159659 ↗
Known as Levometadona ChEMBL registry synonym — accepted as the source's own label CHEMBL159659 ↗
Known as Levomethadone HCl “Extended-release levomethadone HCl 187 mg administered orally once on Day 8 of the study.” NCT05251376 ↗
Known as Levothyl ChEMBL registry synonym — accepted as the source's own label CHEMBL159659 ↗
Known as Polamivet ChEMBL registry synonym — accepted as the source's own label CHEMBL159659 ↗
Known as R-methadone “Same individuals treated with racemic methadone and switched to levomethadone (R-methadone)” NCT04254731 ↗
Modality Small molecule — CHEMBL159659 ↗
Route Oral “Extended-release levomethadone HCl 187 mg administered orally once on Day 8 of the study.” NCT05251376 ↗